Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Santa Ana, California


Purpose:

The purpose of this study is to evaluate the safety of JTT-302 when administered for eight or 12 weeks in subjects with low HDL-C levels and to determine the effect of JTT-302 on lipid parameters and CETP activity and mass.


Criteria:

Inclusion Criteria: - Subjects must have successfully completed the 4-week treatment period of study AT302-U-06-003 Exclusion Criteria: - Females who are pregnant or lactating, and females of child bearing potential who are not using an effective method of contraception - Use of Cytochrome P450 3A4 inducers or inhibitors, as defined in the protocol - Subjects who cannot follow the prescription and OTC medication restrictions defined in the protocol - Flu-shots not permitted during the study, including the follow-up period.


NCT ID:

NCT00748852


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Santa Ana, California
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.